Home > Insider Trading > Filing (0000891293-23-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891293	Cti Biopharma Corp	CTIC	Pharmaceutical Preparations (2834)	911533912

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276750	David Kirske	C/O Cti Biopharma Corp. 3101 Western Ave., Suite 800 Seattle WA 98121	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-29	13,174	$0.95	30,087	No	4	M	Direct
Common Stock	Disposition	2022-12-29	13,174	$6.00	16,913	No	4	S	Direct
Common Stock	Acquisiton	2022-12-30	214	$5.11	17,127	No	4	A	Direct
Common Stock	Acquisiton	2022-12-30	12,000	$0.95	29,127	No	4	M	Direct
Common Stock	Disposition	2022-12-30	12,000	$6.00	17,127	No	4	S	Direct
Common Stock	Acquisiton	2022-12-30	800	$0.95	17,927	No	4	M	Direct
Common Stock	Disposition	2022-12-30	800	$6.01	17,127	No	4	S	Direct
Common Stock	Acquisiton	2022-12-30	1,047	$0.95	18,174	No	4	M	Direct
Common Stock	Disposition	2022-12-30	1,047	$6.01	17,127	No	4	S	Direct
Common Stock	Acquisiton	2023-01-03	27,021	$0.95	44,148	No	4	M	Direct
Common Stock	Disposition	2023-01-03	27,021	$6.01	17,127	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2022-12-29	13,174	$0.00	13,174	$0.95
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2022-12-30	12,000	$0.00	12,000	$0.95
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2022-12-30	800	$0.00	800	$0.95
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2022-12-30	1,047	$0.00	1,047	$0.95
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2023-01-03	27,021	$0.00	27,021	$0.95

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
311,084	2029-02-19	No	4	M	Direct
299,084	2029-02-19	No	4	M	Direct
298,284	2029-02-19	No	4	M	Direct
297,237	2029-02-19	No	4	M	Direct
270,216	2029-02-19	No	4	M	Direct

Footnotes

This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person.
Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.07, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
One third of the shares underlying the option vested on 2/19/20 and annually thereafter until all the underlying shares were fully vested on 2/19/2022.